Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MI › Alpena › NPI 1619914652
Hospital

Mymichigan Medical Center Alpena

Mymichigan Medical Center Alpena was paid $21.24M by Medicaid between Jan 2018 and Dec 2024, across 334 billing codes. Its largest line is 99284, emergency room visit (serious) — 12% of everything it billed.

33Billing provider infoMYMICHIGAN MEDICAL CENTER ALPENA
ALPENA, MI 49707
33aNPI1619914652assigned 05/31/2006
28Total paid$21.24M
24GClaims759,989
24DCodes billed334
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Rural Acute Care Hospital providers in Michigan

Rank by total paid#1 of 5
Median peer was paid$13.93M
This provider vs. median1.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official JAMES, SARAH controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201880,924$2.22M
2019100,288$2.45M
202083,699$2.23M
2021106,324$3.09M
2022131,103$3.65M
2023139,971$4.14M
2024incomplete117,680$3.46M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 12% 13,742 12,640 $2.55M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 10% 6,670 6,122 $2.19M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 8.8% 38,034 32,785 $1.87M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 7.5% 13,881 13,122 $1.59M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3.9% 8,891 7,938 $829K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 3.8% 9,788 6,819 $815K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3.8% 34,251 10,885 $805K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 3.0% 4,766 2,607 $630K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.7% 4,270 4,096 $567K
J9271 Injection, pembrolizumab, 1 mg 2.6% 87 67 $544K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 2.3% 26,356 8,699 $478K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.1% 6,632 6,405 $444K
322 more codes
96375 Therapeutic injection; each additional sequential IV push 1.6% 11,500 $341K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.5% 1,537 $322K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.5% 12,474 $310K
70450 Computed tomography, head or brain; without contrast material 1.4% 3,078 $299K
71046 Radiologic examination, chest; 2 views 1.4% 8,239 $292K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.3% 3,142 $278K
96361 Intravenous infusion, hydration; each additional hour 1.2% 8,528 $249K
Q5103 Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg 1.0% 325 $217K
90834 Psychotherapy session, about 45 minutes <1% 2,975 $208K
94060 <1% 1,615 $201K
77067 Screening mammography, bilateral, including computer-aided detection <1% 4,001 $190K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 887 $174K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 1,629 $169K
71045 Radiologic examination, chest; single view <1% 4,517 $163K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 365 $157K
59025 Fetal non-stress test <1% 1,698 $151K
97161 <1% 2,992 $148K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 4,689 $135K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,218 $124K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 4,672 $120K
G0378 Hospital observation service, per hour <1% 1,824 $120K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 372 $120K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 640 $112K
80061 Lipid panel <1% 6,013 $110K
76830 Ultrasound, transvaginal <1% 1,918 $109K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 2,059 $106K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 989 $105K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 2,548 $103K
96367 <1% 3,126 $103K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 894 $103K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 14,370 $95K
71275 Computed tomographic angiography, chest, with contrast material <1% 995 $89K
97162 <1% 1,646 $88K
71250 <1% 1,755 $88K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 767 $86K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 183 $86K
90832 Psychotherapy session, about 30 minutes <1% 1,095 $81K
36591 <1% 2,546 $73K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 161 $65K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 3,270 $64K
72110 <1% 1,624 $60K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 1,290 $59K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 1,327 $49K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 7,490 $45K
76801 <1% 787 $45K
96417 <1% 1,218 $44K
76642 <1% 1,088 $43K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 2,767 $40K
80053 Comprehensive metabolic panel <1% 34,580 $39K
90791 Psychiatric diagnostic evaluation <1% 528 $39K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 347 $39K
73030 <1% 1,911 $39K
73564 <1% 1,189 $37K
96415 <1% 928 $36K
84443 Thyroid stimulating hormone (TSH) <1% 10,207 $35K
73630 <1% 2,267 $35K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 40,210 $34K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,608 $33K
76536 <1% 722 $33K
97035 <1% 6,249 $33K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,556 $32K
94726 <1% 1,730 $32K
77063 Screening digital breast tomosynthesis, bilateral <1% 2,492 $31K
86900 <1% 2,889 $30K
73130 <1% 1,821 $28K
73610 <1% 1,858 $28K
93971 <1% 496 $27K
90472 Immunization administration, each additional vaccine (list separately) <1% 870 $27K
97163 <1% 391 $21K
95811 <1% 56 $21K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,622 $21K
74018 <1% 998 $19K
72100 <1% 543 $19K
72141 <1% 129 $19K
73110 <1% 1,185 $19K
97014 <1% 2,380 $18K
73502 <1% 875 $16K
G0433 Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening <1% 1,539 $15K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 29 $15K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 252 $15K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,916 $15K
97165 <1% 300 $15K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 2,549 $14K
77065 Tomosynthesis, mammo <1% 315 $13K
83036 Hemoglobin; glycosylated (A1C) <1% 4,552 $13K
72125 Computed tomography, cervical spine; without contrast material <1% 1,118 $12K
82728 <1% 2,859 $12K
36415 Collection of venous blood by venipuncture <1% 37,608 $12K
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test <1% 739 $11K
71271 <1% 188 $11K
Q3014 Telehealth originating site facility fee <1% 855 $10K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,434 $10K
96416 <1% 64 $10K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,153 $10K
82607 <1% 2,309 $9K
93017 <1% 367 $8K
87086 Culture, bacterial; quantitative colony count, urine <1% 5,591 $8K
73562 <1% 297 $8K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 5,209 $8K
96523 <1% 462 $8K
20553 <1% 72 $8K
87653 <1% 652 $8K
90686 <1% 535 $7K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 24 $7K
83550 <1% 2,489 $7K
88142 <1% 753 $7K
87081 <1% 4,377 $7K
72050 <1% 136 $6K
84439 <1% 2,941 $6K
86803 <1% 1,180 $6K
80048 Basic metabolic panel (calcium, ionized) <1% 4,979 $6K
76770 <1% 101 $6K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 311 $6K
84702 <1% 1,517 $6K
83540 <1% 2,673 $6K
73221 <1% 43 $5K
87340 <1% 1,397 $5K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 453 $5K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 4,616 $5K
96127 <1% 517 $4K
83880 <1% 1,809 $4K
36430 <1% 28 $4K
93225 <1% 86 $4K
85027 <1% 2,371 $4K
97116 <1% 348 $4K
83735 <1% 7,683 $4K
73560 <1% 397 $4K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 326 $4K
G0260 Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography <1% 12 $4K
90677 <1% 14 $3K
81001 <1% 16,463 $3K
84481 <1% 810 $3K
90678 <1% 12 $3K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 68 $3K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 220 $3K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 55 $3K
73080 <1% 214 $3K
84146 <1% 833 $3K
20552 <1% 32 $3K
86592 <1% 1,463 $3K
73140 <1% 106 $3K
90474 <1% 224 $3K
86762 <1% 610 $3K
97597 <1% 40 $3K
87088 <1% 1,573 $3K
87186 <1% 1,746 $3K
86850 <1% 2,711 $3K
90837 Psychotherapy session, about an hour <1% 32 $2K
86140 <1% 3,567 $2K
72131 <1% 54 $2K
82746 <1% 588 $2K
95806 <1% 28 $2K
87070 <1% 895 $2K
77066 Tomosynthesis, mammo <1% 40 $2K
72072 <1% 76 $2K
P9016 Red blood cells, leukocytes reduced, each unit <1% 18 $2K
94618 <1% 140 $2K
Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory <1% 137 $2K
80306 <1% 2,865 $2K
82570 <1% 852 $2K
88342 <1% 122 $2K
96411 <1% 70 $2K
93925 <1% 14 $2K
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 1,269 $2K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 328 $2K
80076 <1% 499 $1K
81025 <1% 7,049 $1K
87276 <1% 4,459 $1K
85610 <1% 4,853 $1K
85652 <1% 2,531 $1K
87077 <1% 870 $1K
97012 <1% 192 $1K
83615 <1% 1,064 $1K
83970 <1% 79 $1K
87275 <1% 4,459 $1K
76882 <1% 24 $1K
86703 <1% 209 $1K
82951 <1% 178 $1K
90480 <1% 27 $1K
73090 <1% 86 $929.44
85730 <1% 2,355 $921.67
83690 <1% 5,268 $901.30
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,199 $866.22
77080 <1% 13 $842.92
76870 <1% 26 $815.01
G0008 Administration of influenza virus vaccine <1% 126 $797.85
86901 <1% 2,891 $728.91
73523 <1% 15 $713.31
82043 <1% 315 $679.32
85018 <1% 778 $630.73
84156 <1% 525 $626.97
71101 <1% 37 $624.18
90656 <1% 38 $589.00
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 29 $580.02
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 39 $572.44
82950 <1% 278 $556.05
85046 <1% 364 $534.89
87220 <1% 418 $524.68
0013A <1% 16 $488.53
87430 <1% 2,475 $483.90
87205 <1% 378 $440.86
87075 <1% 363 $438.35
88312 <1% 97 $371.69
74019 <1% 13 $364.50
83655 <1% 73 $360.52
85379 <1% 1,749 $359.14
86481 <1% 12 $354.92
84703 <1% 1,730 $352.06
87807 <1% 909 $310.10
84403 <1% 28 $307.21
94010 <1% 13 $305.35
82550 <1% 334 $293.99
81002 <1% 289 $293.73
72040 <1% 12 $265.20
82565 <1% 182 $258.84
87040 <1% 1,528 $249.11
70486 <1% 12 $247.08
73590 <1% 12 $241.65
87797 <1% 16 $222.48
97032 <1% 33 $205.36
84112 <1% 14 $181.38
86923 <1% 19 $175.50
12001 <1% 97 $171.68
80069 <1% 56 $163.00
73060 <1% 14 $152.09
83605 <1% 5,536 $151.32
84100 <1% 369 $147.72
90715 <1% 596 $136.09
85014 <1% 139 $127.33
87808 <1% 29 $106.07
84145 <1% 460 $102.55
70498 <1% 13 $100.63
86038 <1% 13 $97.81
80178 <1% 48 $87.48
82962 <1% 4,185 $86.08
88304 <1% 121 $85.57
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 485 $62.74
84484 <1% 5,804 $46.62
82150 <1% 14 $41.11
82140 <1% 32 $38.36
87420 <1% 13 $36.64
88313 <1% 267 $36.25
85045 <1% 27 $34.48
84460 <1% 16 $33.73
84450 <1% 16 $32.96
80164 <1% 14 $28.57
82378 <1% 23 $20.74
86308 <1% 28 $12.84
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 4,582 $1.09
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 0% 1,043 $0.00
J7030 Infusion, normal saline solution , 1000 cc 0% 11,286 $0.00
99152 0% 48 $0.00
J2405 Injection, ondansetron hydrochloride, per 1 mg 0% 9,794 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 533 $0.00
94729 0% 1,722 $0.00
J7120 Ringers lactate infusion, up to 1000 cc 0% 3,286 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 92 $0.00
J2270 Injection, morphine sulfate, up to 10 mg 0% 1,577 $0.00
J1756 Injection, iron sucrose, 1 mg 0% 1,380 $0.00
94799 0% 180 $0.00
90670 0% 131 $0.00
J1200 Injection, diphenhydramine hcl, up to 50 mg 0% 3,732 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 1,256 $0.00
J0640 Injection, leucovorin calcium, per 50 mg 0% 73 $0.00
94664 0% 624 $0.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 0% 832 $0.00
90633 0% 143 $0.00
90700 0% 54 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 226 $0.00
86318 0% 352 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 246 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 249 $0.00
93226 0% 86 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 57 $0.00
90681 0% 128 $0.00
J9190 Injection, fluorouracil, 500 mg 0% 108 $0.00
J1644 Injection, heparin sodium, per 1000 units 0% 165 $0.00
J1050 Injection, medroxyprogesterone acetate, 1 mg 0% 67 $0.00
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg 0% 78 $0.00
J3489 Injection, zoledronic acid, 1 mg 0% 14 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 23 $0.00
J1020 Injection, methylprednisolone acetate, 20 mg 0% 14 $0.00
J1650 Injection, enoxaparin sodium, 10 mg 0% 16 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 82 $0.00
J2550 Injection, promethazine hcl, up to 50 mg 0% 17 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 0% 7,593 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 0% 1,467 $0.00
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 0% 5,103 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 0% 594 $0.00
J2469 Injection, palonosetron hcl, 25 mcg 0% 1,123 $0.00
J1170 Injection, hydromorphone, up to 4 mg 0% 4,648 $0.00
96368 0% 482 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 0% 423 $0.00
94760 0% 550 $0.00
96376 0% 2,644 $0.00
J1885 Injection, ketorolac tromethamine, per 15 mg 0% 8,165 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 0% 5,138 $0.00
A9270 Non-covered item or service 0% 1,852 $0.00
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care 0% 916 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 1,858 $0.00
J2704 Injection, propofol, 10 mg 0% 1,734 $0.00
90647 0% 314 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 824 $0.00
J9045 Injection, carboplatin, 50 mg 0% 154 $0.00
J1040 Injection, methylprednisolone acetate, 80 mg 0% 418 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 0% 303 $0.00
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 0% 25 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 0% 244 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 0% 162 $0.00
J2060 Injection, lorazepam, 2 mg 0% 1,205 $0.00
80320 0% 30 $0.00
90723 0% 214 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 331 $0.00
82803 0% 75 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 56 $0.00
J3480 Injection, potassium chloride, per 2 meq 0% 202 $0.00
88307 0% 12 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 13 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 69 $0.00
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 0% 15 $0.00
J3360 Injection, diazepam, up to 5 mg 0% 39 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialJAMES, SARAH (MANAGER, PROVIDER ENROLLMENT)
Parent organizationMYMICHIGAN HEALTH
Same official

Other billing entities under JAMES, SARAH

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.